ELAFIBRANOR
Elafibranor 80 mg tablet, 30
ELAFIBRANOR (15107D)
15107D
Body System:
Manner of administration:Oral
Restriction
Indication: Primary biliary cholangitis (previously known as Primary biliary cirrhosis)
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $5,885.13 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Iqirvo | |||||